Global CDMO Market Set for 7.0% CAGR Growth, Surpassing $191 Billion by 2029
January 30, 2025 09:36 ET
|
BCC Research LLC
Boston, Jan. 30, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the demand for Global Market Opportunities and Competitive Landscape for CDMO was valued at $128.0 billion...
Oligonucleotide CDMO Global Market Report 2025, with Profiles of Bachem, Thermo Fisher Scientific, Agilent Technologies, EUROAPI, ST Pharm, Wuxi Apptec, Maravai Lifesciences, Biospring and More
January 30, 2025 05:33 ET
|
Research and Markets
Dublin, Jan. 30, 2025 (GLOBE NEWSWIRE) -- The "Oligonucleotide CDMO Market by Service (Contract Manufacturing (Clinical, Commercial), Development), Type (ASO, SiRNA, (CPG Oligos, gRNA)), Application...
Unlocking Growth: Thermoformed Shallow Trays Market to Reach US$ 8.8 Billion by 2034, Driven by Sustainability and Industry Demand | TMR Analysis
January 27, 2025 08:31 ET
|
Transparency Market Research
Wilmington, Delaware, Transparency Market Research Inc. –, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The global thermoformed shallow trays market is poised for significant growth, with an estimated value of...
Lifecore Biomedical Announces Special Stockholder Meeting
January 17, 2025 17:24 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
United States Oral Solid Dosage Contract Manufacturing Market Set to Reach $11.70 Billion by 2029
January 09, 2025 11:01 ET
|
Research and Markets
Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "United States Oral Solid Dosage Contract Manufacturing Market, By Region, Competition, Forecast & Opportunities, 2019-2029F" report has been added...
Growth Trends in the High Potency API Contract Manufacturing Market, Forecast to 2035 - Why Pharma Giants are Turning to CMOs for High-Potency API Production
January 08, 2025 10:14 ET
|
Research and Markets
Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "High Potency API Contract Manufacturing Market by Product, Synthesis, Application, Dosage Form, End User and Region" report has been added to ...
Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million
January 07, 2025 09:00 ET
|
Lifecore Biomedical, Inc.
Company Believes it is Well Positioned for Mid-Term and Long-Term Growth asCurrent Capacity Continues to Support up to $300 Million in Annual Revenue CHASKA, Minn., Jan. 07, 2025 (GLOBE NEWSWIRE)...
Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference
January 06, 2025 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update
January 02, 2025 16:05 ET
|
Lifecore Biomedical, Inc.
-- Recorded Revenues of $32.6 Million for Q2 Fiscal 2025 -- -- Signed Multiple Development Agreements with New Customers -- -- Strengthened Balance Sheet with Financing Raising Approximately $24.3...
Contract Pharmaceutical Dose Manufacturing Industry Research: Composition, Size, Market Share and Outlook for GLP-1 Receptor Agonist Products
December 23, 2024 10:18 ET
|
Research and Markets
Dublin, Dec. 23, 2024 (GLOBE NEWSWIRE) -- The "Contract Pharmaceutical Dose Manufacturing Industry: Composition, Size, Market Share and Outlook - 2024 Edition" report has been added to ...